Weight loss may not fully reset fat tissue

Clinical takeaway: Counsel patients that regain is common after incretin therapy stops, and watch for human data on whether lingering cellular changes contribute to weight return.

Incretin drugs produce substantial weight loss, but patients generally need to stay on them to keep the weight off. Stopping is commonly followed by weight coming back and cardiometabolic gains slipping. Many people may therefore go through repeated cycles of loss and return, which makes what each cycle does to the body a practical question. 

Some of the answer is already in hand. Obesity-related changes in the body’s fat stores improve as patients lose weight, but some remain. This review weighs the human evidence against the animal data on which changes reverse, which persist, and which drive disease. 

Weight loss reverses much of the cellular stress in human fat tissue but not all of it. Fat samples taken before and after therapeutic weight loss showed many senescence and stress programs reversed, along with a rise in mitochondrial metabolism and substrate cycling. A subset of obesity-associated gene activity changes in fat tissue cells stayed in place after substantial weight loss. 

Fibrosis may be among the changes that linger. It has been associated with poorer weight-loss response after bariatric surgery, though not in every cohort. Incretin therapy shrinks fat cells, improves insulin sensitivity and lipid handling, and reduces inflammatory stress, likely through relief of nutrient pressure. Direct effects on fat tissue have been seen in mice, with little evidence yet in people. 

Fat tissue may carry a lasting memory of obesity that speeds regain, and the case for it rests on mouse work. Formerly obese mice kept activated macrophages and memory-like T cell states after weight normalization, and their fat cells carried epigenetic marks that appeared to prime inflammatory programs. Those mice rapidly rebuilt visceral fat during regain. Mice that cycled weight had worse insulin sensitivity than mice that gained continuously to a similar final weight. Whether the same mechanisms shape regain in people is not known. 

“Weight loss relieves chronic nutrient stress and reverses many features of adipose dysfunction, but recovery can be incomplete and may alter responses to subsequent metabolic challenge,” the authors conclude. “Defining which changes are reversible, which persist as tissue memory, and which directly drive disease will be essential for developing therapies that complement weight loss by restoring healthy adipose remodeling and metabolic resilience.” 

Source: Drareni K, et al. (2026 Nov 5) Science. When fat adapts: From physiological remodeling to disease